Topic Hub
6 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 6 of 6 clinical reviews.
A clinician-reviewed guide to Vyvanse (lisdexamfetamine) delayed-onset side effects, including growth suppression, cardiovascular changes, psychiatric emergence, and dependence, with citations to FDA labeling, FAERS, and clinical trials.
Read clinical reviewA clinical breakdown of Vyvanse (lisdexamfetamine) adverse events by frequency, severity, and patient phenotype, using trial data, FDA labeling, and FAERS reports to guide prescribing and monitoring decisions.
Read clinical reviewA data-driven breakdown of Vyvanse (lisdexamfetamine) adverse event rates drawn from key ADHD and BED trials, FDA labeling, FAERS reports, and post-market literature, with specific incidence numbers per 200-word section.
Read clinical reviewA clinician-reviewed guide to Vyvanse (lisdexamfetamine) side effects, including adverse events that may persist or become permanent, with citations from FDA labeling, FAERS, and peer-reviewed trials.
Read clinical reviewA clinician-reviewed guide to the rare but serious adverse events associated with Vyvanse (lisdexamfetamine), covering cardiovascular risks, psychiatric complications, serotonin syndrome, and FDA safety data with primary-source citations.
Read clinical reviewA clinician-reviewed guide to Vyvanse (lisdexamfetamine) withdrawal and discontinuation syndrome, covering symptoms, timeline, risk factors, management strategies, and FDA labeling requirements.
Read clinical review